An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment

Adoptive cellular therapy with chimeric antigen receptor (CAR) T cells has emerged as a potential novel treatment for various cancers. In this study, we have generated CAR T cells targeting mucin-1 (MUC1), which is an aberrantly glycosylated antigen overexpressed on breast cancer cells. Two differen...

Full description

Bibliographic Details
Main Authors: Nattarika Khuisangeam, Sirirut Jewmoung, Rattapoom Thaiwong, Suparat Tudsamran, Nattiya Hirankarn, Koramit Suppipat, Supannikar Tawinwung
Format: Article
Language:English
Published: Hindawi Limited 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/2449373